Teleflex: (NYSE: TFX)

$79.87

-0.55 (-0.68%)

Volume 115,976

May 20 04:05 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		79.80 - 80.72
	
		52wk Low - High
		57.26 - 87.46
	
		Previous Close
		80.42
	
		Avg. Volume
		366,600
	
		Industry
		MED INSTRUMENTS
	
		Market Cap
		3.30 B
	
		Div - Yield
		1.36 - 1.69
	
		Beta
		0.74
	
		PE (Forward)
		16.64
	
		Current Year Est.
		4.83
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		114 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/16/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            16.64
                        
                            PEG Ratio
                            1.66
                        
                            Current Year Est.
                            4.83
                        
                            Current Quarter Estimate
                            1.17
                        
                            Most Accurate Estimate
                            1.17
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-06-2013
                        
                            EPS Last Year
                            4.35
                        
                            Expected Earnings Growth
                            10.00%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Teleflex is a growth-oriented company managed for long-term, consistent performance. Their diversified operations manufacture products and provide services for the automotive, marine, industrial, medical and aerospace markets worldwide.  They Seek leadership in technical market niches.  Maintain balance and diversification among their markets.  Emphasize their international activities.  Search for new technology in current markets.   
Full TFX Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
TFX Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	1.17	1.21	4.83	5.58
Number of Estimates	6	6	6	6
Low Estimate	1.14	1.19	4.80	5.32
High Estimate	1.19	1.23	4.86	NA
Year Ago EPS	1.14	1.04	4.40	4.83
EPS Growth	2.49%	16.51%	9.81%	15.49%

More TFX Estimates

Average Earnings Estimates for TFX

EPS Growth for TFX

Industry Analysis

Name	Symbol	Previous Close
TELEFLEX INC	TFX	80.42
NATUS MEDICAL	BABY	14.36
CRYOLIFE INC	CRY	6.34
DELCATH SYS INC	DCTH	0.41
GLOBUS MEDICAL	GMED	15.69
HEARTWARE INTL	HTWR	99.19
MELA SCIENCES	MELA	1.07
OXYSURE SYSTEMS	OXYS	0.90
PACIFIC BIOSCI	PACB	2.42
SUNSHINE HEART	SSH	5.49

Sector:Medical>> Industry:MED INSTRUMENTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

FDA Approves TFX's ISO-Gard Mask

Apr 12, 2013

HeartWare Reveals Public Offering

Mar 18, 2013

FDA Clears Teleflex Needles

Jan 28, 2013

Teleflex Wins GPO Agreement

Jan 22, 2013

FDA Nod for Cepheid's Latest Test

Dec 28, 2012

Teleflex Analyst Day Excerpts

Dec 14, 2012

Teleflex Inc. Enters Oversold Territory

Nov 16, 2012

TFX on Portfolio Expansion Spree

Nov 15, 2012

More TFX Zacks Commentary

Financials

EPS TTM	4.35
Sales	1,551
Net Income	121
Price/Earnings	18.49
Price/Book	1.86
Price/Cash Flow	5.41
Price/Sales	2.08

More TFX Financials

News

BRIEF: Berks ledger: Penn National Gaming, Teleflex - Mcclatchy-Tribune Information Services -- Unrestricted

May 20, 2013

Post Earnings Update: Teleflex Has Climbed 2.9% Higher in Past 2 Weeks (TFX) - Comtex Smartrend(R)

May 20, 2013

Teleflex Announces Launch of its Next Generation Vascular Positioning System(R) - Businesswire

May 20, 2013

Teleflex Earnings Hindsight: Up 2.9% in Last 18 Days (TFX) - Financial News Network Online - Earnings Lookback

May 18, 2013

Teleflex (TFX) Showing Bullish Technicals But Could Break Through $80.95 Resistance - Freshbrewedmedia

May 17, 2013

Teleflex reports net income for Q1, provides outlook for 2013 - Datamonitor

May 17, 2013

Teleflex to Focus on Arrow(R) Advanced Interventional Radiology Portfolio at EuroPCR - Businesswire

May 16, 2013

Teleflex to Present at the Deutsche Bank 38th Annual Health Care Conference - Businesswire

May 15, 2013

See All News Stories on TFX

Broker Recommendations

Current ABR	2.39
ABR (Last Week)	2.39
# of recs in ABR	9
Average Target Price	86.86
Industry Rank by ABR	114 out of 265
Rank in Industry	10 out of 52

More TFX Broker Recommendations

Day Low - High	79.80 - 80.72
52wk Low - High	57.26 - 87.46
Previous Close	80.42
Avg. Volume	366,600
Industry	MED INSTRUMENTS
Market Cap	3.30 B
Div - Yield	1.36 - 1.69
Beta	0.74
PE (Forward)	16.64
Current Year Est.	4.83
Quarterly Earnings ESP	0.00%

PE (Forward)	16.64
PEG Ratio	1.66
Current Year Est.	4.83
Current Quarter Estimate	1.17
Most Accurate Estimate	1.17
Earnings ESP	0.00%
Next Earnings Report Date	08-06-2013
EPS Last Year	4.35
Expected Earnings Growth	10.00%

Username: Password:

Remember me [?]

Teleflex: (NYSE: TFX)

$79.87

-0.55 (-0.68%)

Volume 115,976

May 20 04:05 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED INSTRUMENTS

Zacks Commentary

Financials

News

Broker Recommendations